Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.9900
+0.0235 (2.43%)
Jan 15, 2026, 10:26 AM EST - Market open
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $235.01 million as of January 15, 2026. Its market cap has increased by 798.09% in one year.
Market Cap
235.01M
Enterprise Value
211.93M
1-Year Change
798.09%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has increased from $101.63M to $235.01M, an increase of 131.24%. That is a compound annual growth rate of 13.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 229.43M | 37.44% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |